SCHEMBL29355210

SCHEMBL29355210

COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(NC(=O)CCN5CCCCC5)cc43)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 1.00
▸ PAK1 Q13153 14/20 0.78
▸ NTRK1 P04629 3/20 0.55
▸ FLT3 P36888 3/20 0.55
▸ NTRK3 Q16288 2/20 0.55
▸ NTRK2 Q16620 2/20 0.55
▸ PDGFRB P09619 2/20 0.55
▸ KDR P35968 2/20 0.55
▸ PRKD3 O94806 1/20 0.55
▸ ABL1 P00519 1/20 0.55
▸ RET P07949 1/20 0.55
▸ LTK P29376 1/20 0.55
▸ MAP2K2 P36507 1/20 0.55
▸ CSNK1A1 P48729 1/20 0.55
▸ CDK8 P49336 1/20 0.55
▸ CDK7 P50613 1/20 0.55
▸ MAP2K1 Q02750 1/20 0.55
▸ MST1R Q04912 1/20 0.55
▸ AURKB Q96GD4 1/20 0.55
▸ CLK4 Q9HAZ1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29537607 1.00 MAPK1 (1.00) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8428761 1.00 MAPK1 (1.00) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL6266403 1.00 MAPK1 (1.00) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8415627 0.87 PAK1 (1.00) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8415630 0.87 PAK1 (1.00) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8808140 0.86 PAK1 (0.82) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8585963 0.86 PAK1 (0.82) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8411239 0.82 MAPK1 (0.70) MAPK1PAK1NTRK1FLT3NTRK3
SCHEMBL8411247 0.82 MAPK1 (0.70) MAPK1PAK1NTRK1FLT3NTRK3
Hydrochloric Acid SCHEMBL7554275 0.80 PAK1 (0.77) MAPK1PAK1FLT3PDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4363043-B1 COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS NOVOCURE GMBH (CH) 2026-04-22 — — EP claimed
EP-4629995-A1 COMBINATION THERAPY FOR THE TREATMENT OF GLYOBLASTOMA The University of Florida Research Foundation, Inc. (US) 2025-10-15 — — EP claimed
US-12383738-B2 Compositions and methods for increasing cancer cell sensitivity to alternating electric fields NOVOCURE GMBH (CH) 2025-08-12 — — US claimed
US-12195771-B2 Combination chemotherapy for the treatment of cancer WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2025-01-14 — — US claimed
US-20250001166-A1 COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS NOVOCURE GMBH (CH) 2025-01-02 — — US claimed
EP-4363043-A1 COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS Novocure GmbH (CH) 2024-05-08 — — EP claimed
EP-4334436-A1 METHOD FOR INDUCING HYPERTROPHIC MUSCLE FIBERS FOR INDUSTRIAL MEAT PRODUCTION Yeda Research and Development Co. Ltd (IL) 2024-03-13 — — EP claimed
US-20240074473-A1 METHOD FOR INDUCING HYPERTROPHIC MUSCLE FIBERS FOR INDUSTRIAL MEAT PRODUCTION YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2024-03-07 — — US claimed
CN-117580614-A Compositions and methods for increasing sensitivity of cancer cells to alternating electric fields 诺沃库勒有限责任公司 2024-02-20 — — CN claimed
US-11723891-B2 Drug combinations for use in the treatment of RAS-mutant cancer UMC UTRECHT HOLDING B.V. (NL) 2023-08-15 — — US claimed
US-11590133-B2 Methods and compositions for treatment of BRAF mutant cancers MEMORIAL SLOAN KETTERING CANCER CENTER 2023-02-28 — — US claimed
US-20230001193-A1 COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS BIOPHARMA CREDIT PLC (GB) 2023-01-05 — — US claimed
WO-2023275649-A1 COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS NOVOCURE GMBH (CH) 2023-01-05 — — WO claimed
WO-2022234586-A1 METHOD FOR INDUCING HYPERTROPHIC MUSCLE FIBERS FOR INDUSTRIAL MEAT PRODUCTION YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2022-11-10 — — WO claimed
US-20220211706-A1 Methods and Compositions for Treating Cancer UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2022-07-07 — — US claimed
US-20220195408-A1 COMBINATION CHEMOTHERAPY FOR THE TREATMENT OF CANCER WISCONSIN ALUMNI RESEARCH FOUNDATION 2022-06-23 — — US claimed
US-20220162711-A1 IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER ETH ZURICH (CH) 2022-05-26 — — US claimed
US-11285154-B2 Methods and compositions for treating cancer UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2022-03-29 — — US claimed
US-11286469-B2 Combination chemotherapy for the treatment of cancer WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2022-03-29 — — US claimed
EP-3559276-B1 IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER ETH ZUERICH (CH) 2022-03-23 — — EP claimed
Send feedback